Annual SGA
$8.43 M
-$12.54 M-59.81%
December 31, 2023
Summary
- As of February 21, 2025, APRE annual SGA is $8.43 million, with the most recent change of -$12.54 million (-59.81%) on December 31, 2023.
- During the last 3 years, APRE annual SGA has fallen by -$6.50 million (-43.56%).
- APRE annual SGA is now -59.81% below its all-time high of $20.97 million, reached on December 31, 2022.
Performance
APRE SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$1.61 M
-$245.60 K-13.27%
September 30, 2024
Summary
- As of February 21, 2025, APRE quarterly SGA is $1.61 million, with the most recent change of -$245.60 thousand (-13.27%) on September 30, 2024.
- Over the past year, APRE quarterly SGA has dropped by -$324.70 thousand (-16.82%).
- APRE quarterly SGA is now -89.73% below its all-time high of $15.63 million, reached on June 30, 2022.
Performance
APRE Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$1.25 B
-$13.51 M-1.09%
September 30, 2024
Summary
- As of February 21, 2025, APRE TTM SGA is -$1.25 billion, with the most recent change of -$13.51 million (-1.09%) on September 30, 2024.
- Over the past year, APRE TTM SGA has dropped by -$1.26 billion (-17999.86%).
- APRE TTM SGA is now -1903.39% below its all-time high of -$62.47 million.
Performance
APRE TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
APRE Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -59.8% | -16.8% | -10000.0% |
| 3 y3 years | -43.6% | -53.0% | -8399.4% |
| 5 y5 years | +267.3% | -30.4% | -10000.0% |
APRE Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -59.8% | at low | -89.7% | at low | -86.2% | at low |
| 5 y | 5-year | -59.8% | at low | -89.7% | at low | -423.2% | at low |
| alltime | all time | -59.8% | >+9999.0% | -89.7% | +218.2% | -1903.4% | at low |
Aprea Therapeutics Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $1.61 M(-13.3%) | $7.03 M(-1.6%) |
| Jun 2024 | - | $1.85 M(-4.1%) | $7.14 M(+2.2%) |
| Mar 2024 | - | $1.93 M(+17.4%) | $6.99 M(-17.0%) |
| Dec 2023 | $8.43 M(-59.8%) | $1.64 M(-4.4%) | $8.43 M(-5.4%) |
| Sep 2023 | - | $1.72 M(+1.2%) | $8.90 M(-13.3%) |
| Jun 2023 | - | $1.70 M(-49.5%) | $10.27 M(-57.6%) |
| Mar 2023 | - | $3.37 M(+58.8%) | $24.20 M(-2.5%) |
| Dec 2022 | $20.97 M(+54.8%) | $2.12 M(-31.2%) | $24.82 M(-4.8%) |
| Sep 2022 | - | $3.08 M(-80.3%) | $26.07 M(-1.3%) |
| Jun 2022 | - | $15.63 M(+292.3%) | $26.40 M(+87.1%) |
| Mar 2022 | - | $3.99 M(+18.4%) | $14.11 M(+4.1%) |
| Dec 2021 | $13.55 M(-9.3%) | $3.37 M(-1.4%) | $13.55 M(-10.1%) |
| Sep 2021 | - | $3.41 M(+2.1%) | $15.08 M(-0.4%) |
| Jun 2021 | - | $3.34 M(-2.4%) | $15.14 M(-2.8%) |
| Mar 2021 | - | $3.43 M(-30.0%) | $15.58 M(+4.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | $14.93 M(+73.8%) | $4.90 M(+40.9%) | $14.93 M(+6.9%) |
| Sep 2020 | - | $3.47 M(-8.3%) | $13.97 M(+9.1%) |
| Jun 2020 | - | $3.79 M(+36.4%) | $12.81 M(+20.4%) |
| Mar 2020 | - | $2.78 M(-29.5%) | $10.64 M(+23.8%) |
| Dec 2019 | $8.59 M(+274.5%) | $3.94 M(+70.6%) | $8.59 M(+66.5%) |
| Sep 2019 | - | $2.31 M(+42.6%) | $5.16 M(+48.5%) |
| Jun 2019 | - | $1.62 M(+121.9%) | $3.48 M(+87.1%) |
| Mar 2019 | - | $729.30 K(+44.6%) | $1.86 M(+64.6%) |
| Dec 2018 | $2.29 M(-6.7%) | $504.40 K(-19.1%) | $1.13 M(+80.9%) |
| Sep 2018 | - | $623.70 K | $623.70 K |
| Dec 2017 | $2.46 M(-23.7%) | - | - |
| Jun 2008 | $3.22 M(-44.1%) | - | - |
| Jun 2007 | $5.77 M(-34.3%) | - | - |
| Jun 2006 | $8.79 M(>+9900.0%) | - | - |
| Dec 2004 | $7800.00 | - | - |
FAQ
- What is Aprea Therapeutics annual SGA?
- What is the all time high annual SGA for Aprea Therapeutics?
- What is Aprea Therapeutics annual SGA year-on-year change?
- What is Aprea Therapeutics quarterly SGA?
- What is the all time high quarterly SGA for Aprea Therapeutics?
- What is Aprea Therapeutics quarterly SGA year-on-year change?
- What is Aprea Therapeutics TTM SGA?
- What is the all time high TTM SGA for Aprea Therapeutics?
- What is Aprea Therapeutics TTM SGA year-on-year change?
What is Aprea Therapeutics annual SGA?
The current annual SGA of APRE is $8.43 M
What is the all time high annual SGA for Aprea Therapeutics?
Aprea Therapeutics all-time high annual SGA is $20.97 M
What is Aprea Therapeutics annual SGA year-on-year change?
Over the past year, APRE annual SGA has changed by -$12.54 M (-59.81%)
What is Aprea Therapeutics quarterly SGA?
The current quarterly SGA of APRE is $1.61 M
What is the all time high quarterly SGA for Aprea Therapeutics?
Aprea Therapeutics all-time high quarterly SGA is $15.63 M
What is Aprea Therapeutics quarterly SGA year-on-year change?
Over the past year, APRE quarterly SGA has changed by -$324.70 K (-16.82%)
What is Aprea Therapeutics TTM SGA?
The current TTM SGA of APRE is -$1.25 B
What is the all time high TTM SGA for Aprea Therapeutics?
Aprea Therapeutics all-time high TTM SGA is -$62.47 M
What is Aprea Therapeutics TTM SGA year-on-year change?
Over the past year, APRE TTM SGA has changed by -$1.26 B (-17999.86%)